With the publication of this study jamanetwork.com/journals/jamanetworkopen/fullarticle/2770551, we are now entering a new level of recognition for the use of light therapy for treating neurodegenerative diseases and neurotrauma rehabilitation. The use of transcranial light therapy in treating TBI is now showing to be safe, easily tolerated and effective in making measurable changes in brain physiology. These findings are welcome addition to the published research and clinical programs at Quietmind Fdn. over the past 13 years with the Cognitolite and for 6 years with Vielight's Neuro photobiomodulation devices. We are conducting ongoing trials with Vielight's devices and can offer participants substantial savings and free clinical assessments.
Our hope is to advance further with these techniques and hope to collaborate with the team at Harvard and elsewhere on designing new integrated tools that will deliver the correct amount of light to produce the optimal cognitive and physical responses for people with head trauma and neurodegenerative disorders like Alzheimer's, Parkinson's and ALS. More information on our current clinical trials can be found at www.quietmindfdn.org/trials.html
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.